LIMA1 and prostate cancer: Using PC-3 and DU-145 prostate cancer cell lines, EPLIN expression was significantly reduced compared to primary prostate epithelial cells (PrEC), whereas the prostate specific antigen (PSA) positive LNCaP and LAPC4 prostate cancer cell lines failed to express EPLINα at all [4].